LLS TAP: Pushing Boundaries and Transforming Lives for Patients with Rare Blood Cancers

news
Written By Lara Wilson

One-hour live moderated discussion with The Leukemia & Lymphoma Society's (LLS) Therapy Acceleration Program® (TAP) portfolio partners: Friday, Jan. 26, 2024 at 12 noon EST/9 am PST.

Lara Wilson
Previous

IO-202 Receives FDA Orphan Drug Designation for CMML
Next

Dr Courtney DiNardo Sheds Light on FDA Fast Track Designation and Its Impact on Drug Development